Penanganan bedah tumor sel mast digital pada anjing betina ras campuran geriatrik
Tumor sel mast digital (MCT) pada anjing menghadirkan tantangan bedah karena lokasinya di akrum sering membatasi pencapaian margin onkologis yang memadai. Laporan ini menggambarkan presentasi klinis, manajemen bedah, dan konfirmasi histopatologis dari MCT digital pada anjing geriatrik. Seekor anjing betina ras campuran berusia 15 tahun dengan berat 7,6 kg datang dengan massa di daerah interdigital tungkai. Pemeriksaan klinis menunjukkan bahwa anjing tersebut tetap aktif, tanpa kelainan yang jelas pada postur atau cara berjalan. Karena tumor sel mast digital (MCT) sulit ditangani secara bedah karena keterbatasan jaringan untuk margin yang memadai, eksisi bedah dipilih. Selama operasi, massa ditemukan meluas hingga ke jari IV, sehingga memerlukan eksisi lengkap dengan amputasi jari. Pemeriksaan histopatologis mengkonfirmasi adanya tumor sel mast dengan proliferasi sel mast neoplastik infiltratif. Penanganan pascaoperasi meliputi pembersihan luka, pembalutan Robert Jones yang dimodifikasi, amoksisilin-klavulanat, prednison, dan perawatan luka topikal berbasis asam hipoklorit.
■ INTRODUCTION
Mast cell tumor (MCT) is one of the most common cutaneous neoplasms in dogs and shows marked biological variability, ranging from relatively indolent lesions to aggressive tumors with metastatic potential. Clinically, canine MCTs may present with diverse gross appearances, making definitive diagnosis dependent on cytology or histopathology. Histopathologic evaluation is also important for prognostic interpretation because tumor behavior is influenced by grade, proliferative activity, and margin status (Scase et al., 2006)(Klahn et al., 2022).
Digital MCTs represent a particular clinical challenge because the anatomy of the digit limits the ability to obtain adequate surgical margins while preserving function. For this reason, digit amputation is often considered the most practical option when local infiltration prevents conservative excision (Grassinger et al., 2021)(Abrams et al., 2021). This report describes the surgical management of a digital/interdigital MCT in a geriatric mixed-breed female dog.
■ CASE
History: A dog named Bobby was presented to Windsor Animal Hospital, with a complaint of a mass located in the interdigital region of the limb. The lesion raised concerns because of its distal location and the possibility of progressive local involvement. Signalment: The patient was a 15-yearold mixed-breed female dog weighing 7.6 kg. Presenting status: The dog was alert and active. No obvious abnormalities in posture or gait were observed.
Clinical findings: A mass was identified in the interdigital region of the limb. Grossly, after excision, the mass was spherical, firm, and reddish-yellow. During surgery, the lesion was strongly associated with the tissues surrounding digit IV (Figure 1).
Clinical examination: The patient was active and in a stable general condition, with no apparent locomotor impairment despite the presence of an interdigital mass. Based on the lesion's distal location and concern for local progression, surgical removal was elected.
Additional examination: The excised tissue was subjected to histopathological examination in an external laboratory. Microscopically, the lesion comprised a dense population of neoplastic mast cells with an infiltrative growth pattern.
Differential diagnoses: mast cell tumour, in-flammatory mass, abscess, and other soft tissue neoplasms of the digit/interdigital region. Diagnosis: The final diagnosis was a mast cell tumour (MCT). Prognosis: The prognosis was considered favourable (fausta) based on the treatment course.
Therapy: Surgical excision was performed under Zoletil anaesthesia, as recorded in the case notes. The procedure used a minor surgical set, bone scissors, and a laser. A laser made a circumferential incision around the mass. The mass extended deep around digit IV; therefore, digit IV was amputated using bone scissors for complete excision. The wound bed was checked for haemorrhage, treated with Hydrocyn spray, and bandaged. After surgery, the wound was cleaned with sterile saline and protected with a modified Robert Jones dressing.
Figure 1.A 15-year-old mixed-breed female dog presented with a digital/interdigital mass (A) and surgical findings of the digital mass: (B) preoperative appearance; (C) gross appearance after excision; (D) postoperative wound appearance. laser.
■ RESULTS AND DISCUSSION
This case illustrates the practical challenges of managing digital MCTs in dogs. Although the patient showed no obvious gait abnormality, the lesion had infiltrated the tissues surrounding digit IV, demonstrating that digital tumors may appear clinically limited while already being locally invasive. This supports careful surgical planning even when clinical signs are mild (Grassinger et al., 2021)(Abrams et al., 2021).
Histopathology confirmed that digital masses in dogs can mimic other lesions. In canine MCT, pathology aids in the diagnosis and prognosis with details, such as grade and margins (Scase et al., 2006)(Klahn et al., 2022). Here, infiltrative growth indicated surgery. Digit amputation was justified because wide excision is difficult in digits, where the tissue is limited, and preserving function may hinder tumour control. Amputation ensures better complete removal than conservative excision (Grassinger et al., 2021)(Abrams et al., 2021).
Although molecular evaluation was not performed in this case, KIT-related abnormalities are recognized in canine MCT and may be relevant in more advanced, recurrent, or incompletely excised tumors. Such information may guide targeted therapy in selected patients, although it was not required for the present localized lesion (Halsey et al., 2017)(Macedo et al., 2022).
Postoperative care focused on wound protection, inflammation control, and prevention of secondary infection. The patient received amoxicillin-clavulanate, prednisolone, topical Hydrocyn spray and gel, and regular bandage changes. In distal limb surgery, especially after digit amputation, careful wound management is essential because of limited soft tissue coverage and mechanical stress during ambulation.
■ CONCLUSION
Histopathology confirmed a digital/interdigital mast cell tumour in a geriatric female mixed-breed dog. As the lesion infiltrated the tissues around digit IV, digit amputation was necessary for complete excision, supporting it as an effective local control strategy for digital masses.
Referensi
- Abrams B.E., Putterman A.B., Ruple A., Wavreille V., Selmic L.E.. Variability in tumor margin reporting for soft tissue sarcoma and cutaneous mast cell tumors in dogs: A systematic review. Veterinary Surgery. 2021; 50(2)DOI
- Grassinger J.M., Floren A., Müller T., Cerezo-Echevarria A., Beitzinger C., Conrad D., Törner K., Staudacher M., Aupperle-Lellbach H.. Digital lesions in dogs: a statistical breed analysis of 2912 cases. Veterinary Sciences. 2021; 8DOI
- Halsey C.H., Thamm D.H., Weishaar K.M., Burton J.H., Charles J.B., Gustafson D.L., Avery A.C., Ehrhart E.J.. Expression of phosphorylated KIT in canine mast cell tumor. Veterinary Pathology. 2017; 54(3)DOI
- Klahn S., Dervisis N., Lahmers K., Benitez M.. Evaluation of tumor grade and proliferation indices before and after short-course anti-inflammatory prednisone therapy in canine cutaneous mast cell tumors: a pilot study. Veterinary Sciences. 2022; 9DOI
- Macedo T.R., Queiroz G.F., Casagrande T.A., Alexandre P.A., Brandão P.E., Fukumasu H., Melo S.R., Dagli M.L., Pinto A.C., Matera J.M.. Imatinib mesylate for the treatment of canine mast cell tumors: assessment of the response and adverse events in comparison with the conventional therapy with vinblastine and prednisone. Cells. 2022; 11(3)DOI
- Scase T.J., Edwards D., Miller J., Henley W., Smith K., Blunden A., Murphy S.. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine. 2006; 20(1)DOI
Abrams BE, Putterman AB, Ruple A, Wavreille V, Selmic LE. 2021. Variability in tumor margin reporting for soft tissue sarcoma and cutaneous mast cell tumors in dogs: A systematic review. Veterinary Surgery. 50(2):259-272. https://doi.org/10.1111/vsu.13539 | PMid:33331059
Grassinger JM, Floren A, Müller T, Cerezo-Echevarria A, Beitzinger C, Conrad D, Törner K, Staudacher M, Aupperle-Lellbach H. 2021. Digital lesions in dogs: a statistical breed analysis of 2912 cases. Veterinary sciences. 8(7):136. https://doi.org/10.3390/vetsci8070136 | PMid:34357928 PMCid:PMC8310350
Halsey CH, Thamm DH, Weishaar KM, Burton JH, Charles JB, Gustafson DL, Avery AC, Ehrhart EJ. 2017. Expression of phosphorylated KIT in canine mast cell tumor. Veterinary Pathology. 54(3):387-394. https://doi.org/10.1177/0300985816688943 | PMid:28129097
Klahn S, Dervisis N, Lahmers K, Benitez M. 2022. Evaluation of tumor grade and proliferation indices before and after short-course anti-inflammatory prednisone therapy in canine cutaneous mast cell tu-mors: a pilot study. Veterinary sciences. 9(6):277. https://doi.org/10.3390/vetsci9060277 | PMid:35737330 PMCid:PMC9227510
Macedo TR, de Queiroz GF, Casagrande TA, Alexandre PA, Brandão PE, Fukumasu H, Melo SR, Dagli ML, Pinto AC, Matera JM. 2022. Imatinib mesylate for the treatment of canine mast cell tumors: as-sessment of the response and adverse events in comparison with the conventional therapy with vinblastine and prednisone. Cells. 11(3):571. https://doi.org/10.3390/cells11030571 | PMid:35159380 PMCid:PMC8834544
Scase TJ, Edwards D, Miller J, Henley W, Smith K, Blunden A, Murphy S. 2006. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine. 20(1):151-158. https://doi.org/10.1111/j.1939-1676.2006.tb02835.x | PMid:16496935
Hak Cipta (c) 2026 CC-BY-SA

Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.
Karya ini dilisensikan di bawah Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0).
Lisensi ini mengizinkan siapa pun untuk menyalin, membagikan, menggunakan kembali, mengadaptasi, mengubah, dan mengembangkan karya ini dalam media atau format apa pun, termasuk untuk tujuan komersial, dengan syarat mencantumkan atribusi yang sesuai kepada penulis/pencipta asli, menyertakan tautan ke lisensi, dan menjelaskan jika ada perubahan yang dilakukan.
Apabila karya ini diadaptasi atau dimodifikasi, hasil adaptasinya harus didistribusikan dengan lisensi yang sama atau lisensi yang kompatibel.








